Skip to main content
. 2022 Sep 2;12:818283. doi: 10.3389/fonc.2022.818283

Figure 6.

Figure 6

Potential predictive value of CASP6 in chemotherapy and immunotherapy in the CGGA database. (A) IC50 of temozolomide in the low and high CASP6 expression groups. Low CASP6 expression group (n = 326), high CASP6 expression group (n = 325) (B) Immunotherapy responses in the low and high CASP6 expression groups. Low CASP6 expression group [response: n = 207, (63.50%); non-response: n = 119, (36.50%)], high CASP6 expression group (response: n = 119, (36.62%); non-response: n = 206, (63.38%)) *** P < 0.001.